beauvericin has been researched along with ketoconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, R; Bian, J; Chen, X; Chen, Z; Dai, H; Fu, C; Gao, H; Goodfellow, M; Huang, R; Jiang, Y; Kuai, J; Liu, J; Liu, Z; Min, F; Pei, G; Song, Y; Sun, H; Sun, N; Wang, J; Yan, K; Yang, K; You, J; Yu, Z; Zhang, L; Zhang, S; Zhang, X; Zhang, Y; Zhao, W; Zheng, C; Zhou, G; Zhuo, Y | 1 |
| Dai, R; Mei, L; Zhang, L | 1 |
| Liu, Y; Luan, Y; Tang, X; Tian, T; Yang, M; Zhao, Z; Zhu, M | 1 |
3 other study(ies) available for beauvericin and ketoconazole
| Article | Year |
|---|---|
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
Topics: Algorithms; Animals; Antifungal Agents; Cell Line; Depsipeptides; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Ketoconazole; Mice; Microbial Sensitivity Tests; Mycoses | 2007 |
An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
Topics: Administration, Oral; Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depsipeptides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Ketoconazole; Mass Spectrometry; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Substrate Specificity | 2009 |
Development and Validation of Stability-Indicating Method for the Simultaneous Determination of Ketoconazole and Beauvericin in Pharmaceutical Tablets.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Depsipeptides; Drug Combinations; Drug Contamination; Drug Stability; Humans; Hydrolysis; Ketoconazole; Limit of Detection; Oxidation-Reduction; Photolysis; Tablets | 2016 |